# Implantation of BioSphincter TM for Treatment of Severe Passive Fecal Incontinence

> **NCT05616208** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Cellf Bio LLC** · enrollment: 10 (estimated)

## Conditions studied

- Fecal Incontinence

## Interventions

- **BIOLOGICAL:** Bioengineered Internal Anal Sphincter

## Key facts

- **NCT ID:** NCT05616208
- **Lead sponsor:** Cellf Bio LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-11-02
- **Primary completion:** 2027-07
- **Final completion:** 2027-07
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05616208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05616208, "Implantation of BioSphincter TM for Treatment of Severe Passive Fecal Incontinence". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05616208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*